{"pmid":32345529,"pmcid":"PMC7141443","title":"Extracorporeal Membrane Oxygenation - Crucial Considerations during the Coronavirus Crisis.","text":["Extracorporeal Membrane Oxygenation - Crucial Considerations during the Coronavirus Crisis.","J Cardiothorac Vasc Anesth","Augoustides, John G","32345529"],"journal":"J Cardiothorac Vasc Anesth","authors":["Augoustides, John G"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32345529","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1053/j.jvca.2020.03.060","topics":["Treatment"],"weight":1,"_version_":1666138495440125952,"score":9.490897,"similar":[{"pmid":32285929,"title":"Extracorporeal membrane oxygenation in COVID-19.","text":["Extracorporeal membrane oxygenation in COVID-19.","Cardiol J","Smereka, Jacek","Puslecki, Mateusz","Ruetzler, Kurt","Filipiak, Krzysztof J","Jaguszewski, Milosz","Ladny, Jerzy R","Szarpak, Lukasz","32285929"],"journal":"Cardiol J","authors":["Smereka, Jacek","Puslecki, Mateusz","Ruetzler, Kurt","Filipiak, Krzysztof J","Jaguszewski, Milosz","Ladny, Jerzy R","Szarpak, Lukasz"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32285929","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.5603/CJ.a2020.0053","keywords":["covid-19","ecmo","extracorporeal membrane oxygenation","pneumonia","treatment"],"topics":["Treatment"],"weight":1,"_version_":1666138491366408192,"score":66.46666},{"pmid":32371555,"title":"Utility of extracorporeal membrane oxygenation in COVID-19.","text":["Utility of extracorporeal membrane oxygenation in COVID-19.","Extracorporeal membrane oxygenation (ECMO) is a means of cardiopulmonary support for refractory respiratory and cardiac failure. ECMO is a resource-intensive therapy that can be considered in highly selected patients. Expert centers should employ an evidence-based ARDS treatment algorithm and a multidisciplinary approach to recommending ECMO upon failure of conventional therapy. Caring for ECMO patients requires adequate infection control and safety precautions for healthcare workers.","Cleve Clin J Med","Khan, Rizwan","Anandamurthy, Balaram","McCurry, Kenneth","Krishnan, Sudhir","32371555"],"abstract":["Extracorporeal membrane oxygenation (ECMO) is a means of cardiopulmonary support for refractory respiratory and cardiac failure. ECMO is a resource-intensive therapy that can be considered in highly selected patients. Expert centers should employ an evidence-based ARDS treatment algorithm and a multidisciplinary approach to recommending ECMO upon failure of conventional therapy. Caring for ECMO patients requires adequate infection control and safety precautions for healthcare workers."],"journal":"Cleve Clin J Med","authors":["Khan, Rizwan","Anandamurthy, Balaram","McCurry, Kenneth","Krishnan, Sudhir"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371555","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3949/ccjm.87a.ccc014","topics":["Treatment"],"weight":1,"_version_":1666138496498139137,"score":62.96974},{"pmid":32319081,"title":"Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?","text":["Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?","Anaesthesia","Zochios, V","Brodie, D","Charlesworth, M","Parhar, K K","32319081"],"journal":"Anaesthesia","authors":["Zochios, V","Brodie, D","Charlesworth, M","Parhar, K K"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32319081","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/anae.15099","keywords":["covid-19","decision making","extracorporeal membrane oxygenation","ventilation"],"topics":["Treatment"],"weight":1,"_version_":1666138493613506560,"score":59.852604},{"pmid":32301347,"pmcid":"PMC7175783","title":"Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic.","text":["Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic.","Future Cardiol","Pravda, Nili Schamroth","Pravda, Miri Schamroth","Kornowski, Ran","Orvin, Katia","32301347"],"journal":"Future Cardiol","authors":["Pravda, Nili Schamroth","Pravda, Miri Schamroth","Kornowski, Ran","Orvin, Katia"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301347","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.2217/fca-2020-0040","keywords":["covid-19","ecmo","extracorporeal membrane oxygenation therapy"],"topics":["Treatment"],"weight":1,"_version_":1666138494837194752,"score":59.852604},{"pmid":32243266,"title":"Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China.","text":["Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China.","Severe cases of coronavirus disease 2019 (COVID-19) cannot be adequately managed with mechanical ventilation alone. The role and outcome of extracorporeal membrane oxygenation (ECMO) in the management of COVID-19 is currently unclear. Eight COVID-19 patients have received ECMO support in Shanghai with seven with venovenous (VV) ECMO support and one veno arterial (VA) ECMO during cardiopulmonary resuscitation. As of March 25, 2020, four patients died (50% mortality), three patients (37.5%) were successfully weaned off ECMO after 22, 40, and 47 days support, respectively, but remain on mechanical ventilation. One patient is still on VV ECMO with mechanical ventilation. The partial pressure of oxygen/fractional of inspired oxygen ratio before ECMO initiation was between 54 and 76, and all were well below 100. The duration of mechanical ventilation before ECMO ranged from 4 to 21 days. Except the one emergent VA ECMO during cardiopulmonary resuscitation, other patients were on ECMO support for between 18 and 47 days. In conclusion, ensuring effective, timely, and safe ECMO support in COVID-19 is key to improving clinical outcomes. Extracorporeal membrane oxygenation support might be an integral part of the critical care provided for COVID-19 patients in centers with advanced ECMO expertise.","ASAIO J","Li, Xin","Guo, Zhen","Li, Bailing","Zhang, Xiaolin","Tian, Rui","Wu, Wei","Zhang, Zhongwei","Lu, Yunfei","Chen, Nan","Clifford, Sean P","Huang, Jiapeng","32243266"],"abstract":["Severe cases of coronavirus disease 2019 (COVID-19) cannot be adequately managed with mechanical ventilation alone. The role and outcome of extracorporeal membrane oxygenation (ECMO) in the management of COVID-19 is currently unclear. Eight COVID-19 patients have received ECMO support in Shanghai with seven with venovenous (VV) ECMO support and one veno arterial (VA) ECMO during cardiopulmonary resuscitation. As of March 25, 2020, four patients died (50% mortality), three patients (37.5%) were successfully weaned off ECMO after 22, 40, and 47 days support, respectively, but remain on mechanical ventilation. One patient is still on VV ECMO with mechanical ventilation. The partial pressure of oxygen/fractional of inspired oxygen ratio before ECMO initiation was between 54 and 76, and all were well below 100. The duration of mechanical ventilation before ECMO ranged from 4 to 21 days. Except the one emergent VA ECMO during cardiopulmonary resuscitation, other patients were on ECMO support for between 18 and 47 days. In conclusion, ensuring effective, timely, and safe ECMO support in COVID-19 is key to improving clinical outcomes. Extracorporeal membrane oxygenation support might be an integral part of the critical care provided for COVID-19 patients in centers with advanced ECMO expertise."],"journal":"ASAIO J","authors":["Li, Xin","Guo, Zhen","Li, Bailing","Zhang, Xiaolin","Tian, Rui","Wu, Wei","Zhang, Zhongwei","Lu, Yunfei","Chen, Nan","Clifford, Sean P","Huang, Jiapeng"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243266","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1097/MAT.0000000000001172","link_comment_in":"32341268","locations":["Shanghai","Shanghai","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138492129771523,"score":56.424664}]}